Shayan Mohammadmoradi: Supporting Cardiovascular Research Through Community Action
Shayan Mohammadmoradi, Vascular Biology and Platelet Function Scientist at University of Kentucky, CEO at Moradi Enterprise, shared a post on LinkedIn:
“Today our Cardiovascular Research Team went to Keeneland and it was worth every step!
The 2026 Central Kentucky Heart Walk was a reminder of why we do this work.
You can spend years studying atherosclerosis, platelet biology, and vascular disease at the bench but walking alongside survivors, caregivers, and community members who’ve lived it puts everything in perspective.
To everyone who donated: thank you.
Your generosity funds the research, CPR education, and community outreach that the American Heart Association channels into real, measurable impact.
It comes back to Central Kentucky and it saves lives here.
Our lab will keep doing the science.
We’ll be back next year!”
Stay updated with Hemostasis Today.
-
Jul 7, 2026, 06:19Simone Schoenwaelder: Women Are 25% More Likely to Have Their Stroke Misdiagnosed and Here’s Why
-
Jul 7, 2026, 06:12Dhiraj Bhatia: Extremely Happy to Share Our Review on DNA Nanotechnology in Stroke Repair
-
Jul 7, 2026, 06:04Brian A Beh: An Open Letter to Lisa Murphy Honouring the 30 Years of the Stroke Foundation’s Dedication
-
Jul 7, 2026, 05:55Alan Nurden: A Landmark Review Comparing Hemophilia and Hereditary Angioedema
-
Jul 7, 2026, 05:40Andrew Agwunobi: UConn Health is Proud to Advance Stroke Rehabilitation for Veterans
-
Jul 6, 2026, 22:54Louise St. Germain Bannon: I Wanted to Recognize the Incredible Staff Behind ISTH 2026
-
Jul 6, 2026, 21:46Armghan Ans: UPMC Washington Stroke Program Earns AHA Gold Plus Award for 16th Consecutive Year
-
Jul 6, 2026, 20:31Manik Madaan: Master Transfusion Reactions for USMLE In Less Than 60 Seconds
-
Jul 6, 2026, 19:25Ambreen Kashif: Highlighting the Impact of Temporary Donor Deferrals on Donor Retention